Atul Varadhachary Managing Partner at Fannin Innovation Studio on Biotech and Healthcare Ventures

Atul Varadhachary

Dr. Atul Varadhachary is Managing Partner at Fannin Innovation Studio (formerly AlphaDev, LLC). Fannin is Houston’s leading early-stage life science development group. We partner with leading innovators in the Texas Medical Center to co-found biomedical and life sciences startups for which we serve as the experienced management team. We also host and seed fund our startups. Atul was previously President, U.S. Operations at Reliance Life Sciences (RLS), India’s leading integrated life science company. RLS is part of the Reliance Group, India’s largest private sector company with $67 billion in revenues. As President of Agennix, a late-stage biotechnology company, Atul led development of its lead molecule from preclinical studies into global pivotal Phase III studies, and helped lead the successful sale of the company. Atul served as a Senior Engagement Manager at the global management consulting firm, McKinsey & Co. from 1994 to 2001. He co-founded and ran Pratham Health (now the Niramaya Health Foundation), while on leave of absence from McKinsey. Atul serves on the Niramaya Board and as Pratham USA President. Atul is on the the boards of Pulmotect, RLS, the Center for Public Policy Priorities (CPPP), BreviTest and TiE. He has served on the Board of the Harris Health System, as President of the Indo-American Chamber of Commerce of Greater Houston (IACCGH) and as Adjunct Professor at the Baylor College of Medicine and the Jones Graduate School of Management at Rice University, and on the U. of Houston Biotech Industrial Advisory Committee. He serves on the Houston Technology Center Life Sciences Advisory Committee and the BioHouston Advisory Board. Atul did his medical training at the University of Bombay. He earned a PhD in Physiology from the Johns Hopkins School of Medicine in Baltimore, followed by a postdoctoral fellowship in Biological Chemistry, also at Hopkins, where he was Founding President of the Postdoctoral Association, the first in the U.S.